| Phase 1 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1 | ||||
| NCT06789172 | A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors | Solid Tumours | Recruiting | 2026-06-11 |
Colorectal Cancer (1) · Gastric Cancer (1) · Head & Neck Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Sarcoma (1)